Cerebellar α6-subunit-containing GABAAreceptors: a novel therapeutic target for disrupted prepulse inhibition in neuropsychiatric disorders-Reference-Cited by-同舟云学术

Cerebellar α6-subunit-containing GABAAreceptors: a novel therapeutic target for disrupted prepulse inhibition in neuropsychiatric disorders

Published:2018-05-10 Issue:12 Volume:175 Page:2414-2427
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British Journal of Pharmacology

Author:

Chiou Lih-Chu¹²³^ORCID,Lee Hsin-Jung¹,Ernst Margot⁴^ORCID,Huang Wei-Jan⁵,Chou Jui-Feng¹,Chen Hon-Lie¹,Mouri Akihiro⁶⁷,Chen Liang-Chieh⁵,Treven Marco⁴,Mamiya Takayoshi⁶,Fan Pi-Chuan⁸,Knutson Daniel E⁹^ORCID,Witzigmann Chris⁹,Cook James⁹^ORCID,Sieghart Werner⁴^ORCID,Nabeshima Toshitaka⁶⁷¹⁰

Affiliation:

1. Graduate Institute of Pharmacology; National Taiwan University; Taipei Taiwan

2. Graduate Institute of Brain and Mind Sciences; National Taiwan University; Taipei Taiwan

3. Graduate Institute of Acupuncture Science; Taichung Taiwan

4. Center for Brain Research, Department of Molecular Neurosciences; Medical University Vienna; Vienna Austria

5. Graduate Institute of Pharmacognosy; Taipei Medical University; Taipei Taiwan

6. Department of Chemical Pharmacology, Faculty of Pharmacy; Meijo University; Nagoya Japan

7. Advanced Diagnostic System Research Laboratory, Graduate School of Health Sciences; Fujita Health University; Toyoake Japan

8. Department of Pediatrics, College of Medicine; National Taiwan University; Taipei Taiwan

9. Department of Chemistry and Biochemistry; University of Wisconsin - Milwaukee; Milwaukee WI USA

10. Aino University; Ibaraki Japan

Funder

Foundation for the National Institutes of Health

Japan Society for the Promotion of Science

Ministry of Science and Technology

National Health Research Institutes

National Science Council

Shimadzu Analytical Facility of Southeastern Wisconsin

National Institutes of Health

Austrian Science Fund

Smoking Research Foundation

Nakatomi Foundation

Takeda Science Foundation

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.14198/fullpdf

Reference64 articles.

1. The Concise Guide to PHARMACOLOGY 2017/18: Ligand-gated ion channels;Alexander;Br J Pharmacol,2017a

2. The Concise Guide to PHARMACOLOGY 2017/18: Enzymes;Alexander;Br J Pharmacol,2017b

3. The Concise Guide to PHARMACOLOGY 2017/18: Voltage-gated ion channels;Alexander;Br J Pharmacol,2017c

4. Schizophrenia and cognitive dysmetria: a positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry;Andreasen;Proc Natl Acad Sci U S A,1996

5. Prestimulus effects on human startle reflex in normals and schizophrenics;Braff;Psychophysiology,1978

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The deuterated pyrazoloquinolinone targeting α6 subunit-containing GABAA receptor as novel candidate for inhibition of trigeminovascular system activation: implication for migraine therapy;Frontiers in Pharmacology;2024-08-26

2. New clues for the role of cerebellum in schizophrenia and the associated cognitive impairment;Frontiers in Cellular Neuroscience;2024-05-10

3. Pivotal Role of Slitrk1 in Adult Striatal Cholinergic Neurons in Mice: Implication in Tourette Syndrome;Annals of Neurology;2023-10-12

4. Cerebellar α6GABAA Receptors as a Therapeutic Target for Essential Tremor: Proof-of-Concept Study with Ethanol and Pyrazoloquinolinones;Neurotherapeutics;2023-03

5. Search for Novel Therapies for Essential Tremor Based on Positive Modulation of α6-Containing GABAA Receptors;Tremor and Other Hyperkinetic Movements;2023